Leadership Transition at Roche Canada Pharma

MISSISSAUGA, ON - April 30, 2026 - Roche Canada announced today that Brigitte Nolet, currently President & CEO of Roche Canada Pharma, will assume a new global leadership position as Head of Access, Roche Global Pharma Strategy in Basel, Switzerland, effective May 1, 2026.

During her four-year tenure leading the Canadian Pharma division, Brigitte has been a tireless advocate for patient access to innovative medicines, the value of medicines and the life sciences sector to the Canadian economy, and a champion for reform within the healthcare ecosystem.

“I am deeply grateful for the partnerships and friendships I have built across the healthcare, government, and life sciences sectors in Canada over the past years,” said Brigitte Nolet. “As I move into this next chapter, I do so with absolute confidence in Roche Canada. This organization - and Canada more broadly - is home to some of the finest talent in the world. Our teams have consistently demonstrated a unique ability to adjust dynamically to the evolving needs of healthcare systems and patients. I have seen this organization rise to meet every challenge, and I know that the collective expertise and deep commitment to patients will continue to drive Roche Canada forward.”

While the search for a permanent successor is underway, Dr. Daniel (Dan) Edgcumbe, currently Vice President of Medical & Regulatory Affairs, will also serve as Interim General Manager to ensure a seamless transition. Dan brings a wealth of experience from across Canadian and international healthcare systems to the interim leadership role.

Roche Canada remains steadfast in its long-term commitment to ensuring that innovative medicines reach the patients who need them most, while also fostering a vibrant and evolving healthcare sector.